Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1002-1007, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevenson, H. P.
Right arrow Articles by Sheridan, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevenson, H. P.
Right arrow Articles by Sheridan, B.
Related Collections
Right arrow Hemostasis and Thrombosis
Right arrow Hematology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1998;44:1002-1007.)
© 1998 American Association for Clinical Chemistry, Inc.

Endocrinology and Metabolism

Misleading serum free thyroxine results during low molecular weight heparin treatment

Heather P. Stevenson1, G. Pooler, R. Archbold2, Paul Johnston3, Ian S. Young2, and Brian Sheridan2,a

1 Directorate of Biochemical Medicine, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
Departments of
2 Clinical Biochemistry and
3 Cardiology, Royal Hospitals Trust, Belfast BT12 6BA, UK.
a Author for correspondence. Fax 44-1232-312014.

Measured free thyroxine concentrations in serum increase markedly after intravenous heparin administration, but the effect of heparin administered subcutaneously has not been adequately documented. We found in vitro increases of up to 63% in measured FT4 after a single dose of subcutaneous heparin (enoxaparin, 2000 units) in nine healthy volunteers, and the magnitude of these increases was correlated with initial serum triglyceride concentrations (r = 0.93, P <0.005) and in vitro free fatty acid release (r = 0.88, P <0.005). In 10 cardiac inpatients receiving repeated doses of enoxaparin (2000 units twice daily), measured FT4 increased by up to 171% in specimens taken 2–6 h after injection. When specimens were obtained 10 h after injection, the effect appeared to be minimized, with in vitro increases of <40%, but such increases may still be sufficient to cause interpretative errors. If FT4 estimation is absolutely necessary in patients receiving enoxaparin, specimens should be taken >=10 h postdose and analyzed within 24 h.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. Sapin and M. d'Herbomez
Free Thyroxine Measured by Equilibrium Dialysis and Nine Immunoassays in Sera with Various Serum Thyroxine-binding Capacities
Clin. Chem., September 1, 2003; 49(9): 1531 - 1535.
[Full Text] [PDF]

Home page
 ANGIOLOGYHome page
H.N. Pavlou, P.A. Kliridis, A.A. Panagiotopoulos, C.P. Goritsas, and P.J. Vassilakos
Euthyroid Sick Syndrome in Acute Ischemic Syndromes
Angiology, November 1, 2002; 53(6): 699 - 707.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
J. E.M. Midgley
Direct and Indirect Free Thyroxine Assay Methods: Theory and Practice
Clin. Chem., August 1, 2001; 47(8): 1353 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. De Smet, J. Van Kaer, H. Liebich, G. Lesaffer, A. Verstraete, A. Dhondt, P. Duym, N. Lameire, and R. Vanholder
Heparin-induced Release of Protein-bound Solutes during Hemodialysis Is an in Vitro Artifact
Clin. Chem., May 1, 2001; 47(5): 901 - 909.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Sapin, J.-L. Schlienger, F. Gasser, E. Noel, B. Lioure, F. Grunenberger, B. Goichot, and D. Grucker
Intermethod Discordant Free Thyroxine Measurements in Bone Marrow-transplanted Patients
Clin. Chem., March 1, 2000; 46(3): 418 - 422.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.